Response to " Ipilimumab (Yervoy) and the TGN1412 catastrophe"

Research output: Contribution to journalLetterpeer-review

10 Scopus citations
Original languageEnglish (US)
Pages (from-to)590-592
Number of pages3
JournalImmunobiology
Volume217
Issue number6
DOIs
StatePublished - Jun 2012
Externally publishedYes

Keywords

  • CD28
  • CTLA-4
  • Ipilimumab

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Hematology

Cite this